$4.12 Billion is the total value of Artal Group S.A.'s 137 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 117.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QQQ | New | INVESCO QQQ TRput | $571,795,000 | – | 2,058,000 | +100.0% | 13.88% | – |
| BGNE | Buy | BEIGENE LTDsponsored adr | $257,796,000 | +61.0% | 900,000 | +5.9% | 6.26% | +39.7% |
| GS | Buy | GOLDMAN SACHS GROUP INCcall | $175,849,000 | +344.9% | 875,000 | +337.5% | 4.27% | +286.0% |
| BABA | Buy | ALIBABA GROUP HLDG LTDsponsored ads | $124,942,000 | +55.5% | 425,000 | +14.1% | 3.03% | +34.9% |
| MRTX | New | MIRATI THERAPEUTICS INC | $83,025,000 | – | 500,000 | +100.0% | 2.02% | – |
| ALVR | New | ALLOVIR INC | $63,893,000 | – | 2,323,371 | +100.0% | 1.55% | – |
| BEKE | New | KE HLDGS INCsponsored ads | $53,331,000 | – | 870,000 | +100.0% | 1.30% | – |
| IGMS | New | IGM BIOSCIENCES INC | $50,848,000 | – | 688,910 | +100.0% | 1.23% | – |
| BAC | Buy | BK OF AMERICA CORPcall | $48,180,000 | +102.9% | 2,000,000 | +100.0% | 1.17% | +75.9% |
| ABBV | Buy | ABBVIE INCcall | $43,795,000 | +78.4% | 500,000 | +100.0% | 1.06% | +54.7% |
| XLI | Buy | SELECT SECTOR SPDR TRcall | $38,490,000 | +24.5% | 500,000 | +11.1% | 0.93% | +8.0% |
| IMAB | Buy | I MABsponsored ads | $34,097,000 | +251.6% | 725,000 | +123.8% | 0.83% | +205.5% |
| ALBO | Buy | ALBIREO PHARMA INC | $28,411,000 | +114.3% | 851,405 | +70.2% | 0.69% | +86.0% |
| AGEN | Buy | AGENUS INC | $27,600,000 | +146.4% | 6,900,000 | +142.1% | 0.67% | +114.1% |
| ITOS | New | ITEOS THERAPEUTICS INC | $26,990,000 | – | 1,094,047 | +100.0% | 0.66% | – |
| TSHA | New | TAYSHA GENE THERAPIES INC | $25,556,000 | – | 1,140,882 | +100.0% | 0.62% | – |
| MS | New | MORGAN STANLEYcall | $24,175,000 | – | 500,000 | +100.0% | 0.59% | – |
| AAPL | New | APPLE INCcall | $23,162,000 | – | 200,000 | +100.0% | 0.56% | – |
| Buy | TRILLIUM THERAPEUTICS INC | $21,315,000 | +176.5% | 1,500,000 | +57.4% | 0.52% | +139.4% | |
| STNE | Buy | STONECO LTD | $21,156,000 | +88.2% | 400,000 | +37.9% | 0.51% | +63.7% |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $18,620,000 | -0.5% | 1,000,000 | +25.0% | 0.45% | -13.7% |
| ADVM | Buy | ADVERUM BIOTECHNOLOGIES INC | $18,540,000 | -1.3% | 1,800,000 | +100.0% | 0.45% | -14.4% |
| RLAY | New | RELAY THERAPEUTICS INC | $17,036,000 | – | 400,000 | +100.0% | 0.41% | – |
| DHR | New | DANAHER CORPORATION | $16,150,000 | – | 75,000 | +100.0% | 0.39% | – |
| IMUX | Buy | IMMUNIC INC | $14,856,000 | +104.3% | 800,000 | +33.3% | 0.36% | +77.8% |
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $14,730,000 | +0.7% | 1,000,000 | +11.1% | 0.36% | -12.5% |
| OVID | New | OVID THERAPEUTICS INC | $14,350,000 | – | 2,500,000 | +100.0% | 0.35% | – |
| MTCR | New | METACRINE INC | $13,370,000 | – | 1,309,513 | +100.0% | 0.32% | – |
| CRDF | New | CARDIFF ONCOLOGY INC | $12,771,000 | – | 900,000 | +100.0% | 0.31% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INCcall | $11,412,000 | – | 150,000 | +100.0% | 0.28% | – |
| SELB | Buy | SELECTA BIOSCIENCES INC | $11,160,000 | +35.5% | 4,500,000 | +55.2% | 0.27% | +17.8% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $10,224,000 | +23.4% | 237,500 | +18.8% | 0.25% | +6.9% |
| TCRR | Buy | TCR2 THERAPEUTICS INC | $10,160,000 | +89.0% | 500,000 | +42.9% | 0.25% | +64.7% |
| ESPR | New | ESPERION THERAPEUTICS INC NE | $9,293,000 | – | 250,000 | +100.0% | 0.23% | – |
| MCRB | New | SERES THERAPEUTICS INC | $8,493,000 | – | 300,000 | +100.0% | 0.21% | – |
| KYMR | New | KYMERA THERAPEUTICS INC | $8,078,000 | – | 250,000 | +100.0% | 0.20% | – |
| APLT | New | APPLIED THERAPEUTICS INC | $7,889,000 | – | 380,000 | +100.0% | 0.19% | – |
| DYN | New | DYNE THERAPEUTICS INC | $7,470,000 | – | 370,000 | +100.0% | 0.18% | – |
| PMVP | New | PMV PHARMACEUTICALS INC | $7,100,000 | – | 200,000 | +100.0% | 0.17% | – |
| SPRO | Buy | SPERO THERAPEUTICS INC | $6,696,000 | -9.2% | 600,000 | +10.1% | 0.16% | -20.9% |
| ALPN | New | ALPINE IMMUNE SCIENCES INC | $5,213,000 | – | 593,030 | +100.0% | 0.13% | – |
| VXRT | Buy | VAXART INC | $4,988,000 | +181.8% | 750,000 | +275.0% | 0.12% | +142.0% |
| ACIU | Buy | AC IMMUNE SA | $4,880,000 | -26.4% | 1,000,000 | +1.6% | 0.12% | -36.2% |
| ALXO | New | ALX ONCOLOGY HLDGS INC | $3,774,000 | – | 100,000 | +100.0% | 0.09% | – |
| OXY | New | OCCIDENTAL PETE CORP | $3,754,000 | – | 375,000 | +100.0% | 0.09% | – |
| MEIP | Buy | MEI PHARMA INC | $2,371,000 | -19.6% | 760,000 | +6.4% | 0.06% | -30.1% |
| PAND | New | PANDION THERAPEUTICS INC | $1,662,000 | – | 145,000 | +100.0% | 0.04% | – |
| CHMA | New | CHIASMA INC | $1,634,000 | – | 380,000 | +100.0% | 0.04% | – |
| ACET | New | ADICET BIO INC | $1,538,000 | – | 129,335 | +100.0% | 0.04% | – |
| BLU | Buy | BELLUS HEALTH INC NEW | $1,078,000 | -27.1% | 475,000 | +230.4% | 0.03% | -36.6% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.